Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

EMERGENT BIOSOLUTIONS INC. Financing Cash Flow

EMERGENT BIOSOLUTIONS INC. (EBS) reported Financing Cash Flow of -$35.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06

  • EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$24.40M.
  • EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$11.40M.
  • EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$113.90M, a 22880.00% decline year-over-year.
  • EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$15.90M.
  • EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) financing activities for fiscal 2025 was -$136.60M.
  • EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) financing activities for fiscal 2024 was -$190.00M.
  • EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) financing activities for fiscal 2023 was -$535.70M, a 211.33% decline from fiscal 2022.
  • EMERGENT BIOSOLUTIONS INC. net cash provided by (used in) financing activities for fiscal 2022 was $481.20M.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 3 month as first filedNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 6 month as first filedNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 9 month as first filedNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 12 month as first filed
2026-06-30-$24.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$35.80M
10-Q · filed 2026-08-06
-$149.70M
derived: sum of 3 quarters · filed 2026-08-06
-$165.60M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$11.40M
10-Q · filed 2026-05-01
-$125.30M
derived: sum of 2 quarters · filed 2026-05-01
-$141.20M
derived: sum of 3 quarters · filed 2026-05-01
-$147.60M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$113.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$129.80M
derived: sum of 2 quarters · filed 2026-02-27
-$136.20M
derived: sum of 3 quarters · filed 2026-08-06
-$136.60M
10-K · filed 2026-02-27
2025-09-30-$15.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
-$22.30M
derived: sum of 2 quarters · filed 2026-08-06
-$22.70M
10-Q · filed 2025-10-30
-$22.20M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$6.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$6.80M
10-Q · filed 2026-08-06
-$6.30M
derived: sum of 3 quarters · filed 2026-08-06
-$186.60M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$400.00K
10-Q · filed 2026-05-01
$100.00K
derived: sum of 2 quarters · filed 2026-05-01
-$180.20M
derived: sum of 3 quarters · filed 2026-05-01
-$231.10M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31$500.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$179.80M
derived: sum of 2 quarters · filed 2026-02-27
-$230.70M
derived: sum of 3 quarters · filed 2026-02-27
-$190.00M
10-K · filed 2026-02-27
2024-09-30-$180.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
-$231.20M
derived: sum of 2 quarters · filed 2025-10-30
-$190.50M
10-Q · filed 2025-10-30
-$185.80M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30-$50.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$10.20M
10-Q · filed 2025-08-07
-$5.50M
derived: sum of 3 quarters · filed 2026-02-27
-$48.50M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$40.70M
10-Q · filed 2025-05-08
$45.40M
derived: sum of 2 quarters · filed 2026-02-27
$2.40M
derived: sum of 3 quarters · filed 2026-02-27
-$484.50M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31$4.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$38.30M
derived: sum of 2 quarters · filed 2026-02-27
-$525.20M
derived: sum of 3 quarters · filed 2026-02-27
-$535.70M
10-K · filed 2026-02-27
2023-09-30-$43.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$529.90M
derived: sum of 2 quarters · filed 2024-11-07
-$540.40M
10-Q · filed 2024-11-07
-$187.30M
derived: sum of 4 quarters · filed 2025-03-04
2023-06-30-$486.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$497.40M
10-Q · filed 2024-08-07
-$144.30M
derived: sum of 3 quarters · filed 2025-03-04
$85.00M
derived: sum of 4 quarters · filed 2025-03-04
2023-03-31-$10.50M
10-Q · filed 2024-05-02
$342.60M
derived: sum of 2 quarters · filed 2025-03-04
$571.90M
derived: sum of 3 quarters · filed 2025-03-04
$541.20M
derived: sum of 4 quarters · filed 2025-03-04
2022-12-31$353.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04
$582.40M
derived: sum of 2 quarters · filed 2025-03-04
$551.70M
derived: sum of 3 quarters · filed 2025-03-04
$481.20M
10-K · filed 2025-03-04
2022-09-30$229.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11
$198.60M
derived: sum of 2 quarters · filed 2023-12-11
$128.10M
10-Q · filed 2023-12-11
$18.10M
derived: sum of 4 quarters · filed 2024-03-08
2022-06-30-$30.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$101.20M
10-Q · filed 2023-08-09
-$211.20M
derived: sum of 3 quarters · filed 2024-03-08
-$216.20M
derived: sum of 4 quarters · filed 2024-03-08
2022-03-31-$70.50M
10-Q · filed 2023-05-10
-$180.50M
derived: sum of 2 quarters · filed 2024-03-08
-$185.50M
derived: sum of 3 quarters · filed 2024-03-08
-$189.30M
derived: sum of 4 quarters · filed 2024-03-08
2021-12-31-$110.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
-$115.00M
derived: sum of 2 quarters · filed 2024-03-08
-$118.80M
derived: sum of 3 quarters · filed 2024-03-08
-$141.00M
10-K · filed 2024-03-08
2021-09-30-$5.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$8.80M
derived: sum of 2 quarters · filed 2022-11-09
-$31.00M
10-Q · filed 2022-11-09
-$33.30M
derived: sum of 4 quarters · filed 2023-12-11
2021-06-30-$3.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
-$26.00M
10-Q · filed 2022-08-02
-$28.30M
derived: sum of 3 quarters · filed 2023-12-11
$58.80M
derived: sum of 4 quarters · filed 2023-12-11
2021-03-31-$22.20M
10-Q · filed 2022-04-29
-$24.50M
derived: sum of 2 quarters · filed 2023-12-11
$62.60M
derived: sum of 3 quarters · filed 2023-12-11
$67.30M
derived: sum of 4 quarters · filed 2023-12-11
2020-12-31-$2.30M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11
$84.80M
derived: sum of 2 quarters · filed 2023-12-11
$89.50M
derived: sum of 3 quarters · filed 2023-12-11
$69.50M
10-K/A · filed 2023-12-11
2020-09-30$87.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$91.80M
derived: sum of 2 quarters · filed 2021-11-05
$71.80M
10-Q · filed 2021-11-05
$13.90M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$4.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
-$15.30M
10-Q · filed 2021-07-30
-$73.20M
derived: sum of 3 quarters · filed 2022-02-25
-$92.90M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31-$20.00M
10-Q · filed 2021-04-30
-$77.90M
derived: sum of 2 quarters · filed 2022-02-25
-$97.60M
derived: sum of 3 quarters · filed 2022-02-25
$2.50M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31-$57.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
-$77.60M
derived: sum of 2 quarters · filed 2022-02-25
$22.50M
derived: sum of 3 quarters · filed 2022-02-25
-$35.90M
10-K · filed 2022-02-25
2019-09-30-$19.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$80.40M
derived: sum of 2 quarters · filed 2020-11-06
$22.00M
10-Q · filed 2020-11-06
$807.90M
derived: sum of 4 quarters · filed 2021-02-19
2019-06-30$100.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$41.70M
10-Q · filed 2020-07-31
$827.60M
derived: sum of 3 quarters · filed 2021-02-19
$829.30M
derived: sum of 4 quarters · filed 2021-02-19
2019-03-31-$58.40M
10-Q · filed 2020-05-01
$727.50M
derived: sum of 2 quarters · filed 2021-02-19
$729.20M
derived: sum of 3 quarters · filed 2021-02-19
$732.40M
derived: sum of 4 quarters · filed 2021-02-19
2018-12-31$785.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19
$787.60M
derived: sum of 2 quarters · filed 2021-02-19
$790.80M
derived: sum of 3 quarters · filed 2021-02-19
$788.70M
10-K · filed 2021-02-19
2018-09-30$1.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$4.90M
derived: sum of 2 quarters · filed 2019-11-07
$2.80M
10-Q · filed 2019-11-07
$2.72M
10-Q · filed 2018-11-02
-$29.92M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$3.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$1.10M
10-Q · filed 2019-08-02
$1.04M
10-Q · filed 2018-08-03
-$31.62M
derived: sum of 3 quarters · filed 2020-02-25
-$28.36M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31-$2.10M
10-Q · filed 2019-05-08
-$2.13M
10-Q · filed 2018-05-04
-$34.82M
derived: sum of 2 quarters · filed 2020-02-25
-$31.56M
derived: sum of 3 quarters · filed 2020-02-25
-$30.79M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31-$32.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
-$29.46M
derived: sum of 2 quarters · filed 2020-02-25
-$28.69M
derived: sum of 3 quarters · filed 2020-02-25
-$51.40M
10-K · filed 2020-02-25
-$51.40M
10-K · filed 2018-02-23
2017-09-30$3.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$4.03M
derived: sum of 2 quarters · filed 2018-11-02
-$18.68M
10-Q · filed 2018-11-02
-$17.25M
10-Q · filed 2017-11-03
-$13.47M
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30$765.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
-$21.94M
10-Q · filed 2018-08-03
-$16.73M
derived: sum of 3 quarters · filed 2019-02-22
-$61.24M
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31-$22.71M
10-Q · filed 2018-05-04
-$17.50M
derived: sum of 2 quarters · filed 2019-02-22
-$62.01M
derived: sum of 3 quarters · filed 2019-02-22
2016-12-31$5.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
-$39.30M
derived: sum of 2 quarters · filed 2019-02-22
-$19.80M
10-K · filed 2019-02-22
-$19.78M
10-K · filed 2018-02-23
2016-09-30-$44.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
-$25.01M
10-Q · filed 2017-11-03
2016-06-30$19.50M
10-Q · filed 2017-08-04
2015-12-31$14.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$17.99M
derived: sum of 2 quarters · filed 2018-02-23
$24.39M
derived: sum of 3 quarters · filed 2018-02-23
$35.39M
10-K · filed 2018-02-23
2015-09-30$3.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$9.48M
derived: sum of 2 quarters · filed 2015-11-06
$20.48M
10-Q · filed 2015-11-06
$24.17M
derived: sum of 4 quarters · filed 2015-11-06
2015-06-30$6.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$17.40M
10-Q · filed 2015-08-06
$21.09M
derived: sum of 3 quarters · filed 2015-08-06
$21.49M
derived: sum of 4 quarters · filed 2015-11-06
2015-03-31$11.00M
10-Q · filed 2015-05-08
$14.69M
derived: sum of 2 quarters · filed 2015-05-08
$15.09M
derived: sum of 3 quarters · filed 2015-11-06
$17.00M
derived: sum of 4 quarters · filed 2015-11-06
2014-12-31$3.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09
$4.09M
derived: sum of 2 quarters · filed 2015-11-06
$6.00M
derived: sum of 3 quarters · filed 2015-11-06
$198.87M
10-K · filed 2015-03-09
2014-09-30$402.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$2.31M
derived: sum of 2 quarters · filed 2015-11-06
$195.19M
10-Q · filed 2015-11-06
$202.69M
derived: sum of 4 quarters · filed 2015-11-06
2014-06-30$1.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$194.78M
10-Q · filed 2015-08-06
$202.29M
derived: sum of 3 quarters · filed 2015-08-06
$202.94M
derived: sum of 4 quarters · filed 2015-08-06
2014-03-31$192.87M
10-Q · filed 2015-05-08
$200.38M
derived: sum of 2 quarters · filed 2015-05-08
$201.03M
derived: sum of 3 quarters · filed 2015-05-08
$200.49M
derived: sum of 4 quarters · filed 2015-05-08
2013-12-31$7.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09
$8.16M
derived: sum of 2 quarters · filed 2015-03-09
$7.62M
derived: sum of 3 quarters · filed 2015-03-09
$8.61M
10-K · filed 2015-03-09
2013-09-30$647.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$107.00K
derived: sum of 2 quarters · filed 2014-11-10
$1.10M
10-Q · filed 2014-11-10
-$3.21M
derived: sum of 4 quarters · filed 2015-03-09
2013-06-30-$540.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
$455.00K
10-Q · filed 2014-08-08
-$3.86M
derived: sum of 3 quarters · filed 2015-03-09
-$4.23M
derived: sum of 4 quarters · filed 2015-03-09
2013-03-31$995.00K
10-Q · filed 2014-05-12
-$3.32M
derived: sum of 2 quarters · filed 2015-03-09
-$3.69M
derived: sum of 3 quarters · filed 2015-03-09
-$2.02M
derived: sum of 4 quarters · filed 2015-03-09
2012-12-31-$4.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09
-$4.69M
derived: sum of 2 quarters · filed 2015-03-09
-$3.02M
derived: sum of 3 quarters · filed 2015-03-09
-$1.76M
10-K · filed 2015-03-09
2012-09-30-$371.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$1.30M
derived: sum of 2 quarters · filed 2013-11-08
$2.55M
10-Q · filed 2013-11-08
-$415.00K
10-Q · filed 2012-11-01
$2.51M
derived: sum of 4 quarters · filed 2014-03-10
2012-06-30$1.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
$2.92M
10-Q · filed 2013-08-06
$369.00K
10-Q · filed 2012-08-03
$2.88M
derived: sum of 3 quarters · filed 2014-03-10
$17.22M
derived: sum of 4 quarters · filed 2014-03-10
2012-03-31$1.25M
10-Q · filed 2013-05-03
-$730.00K
10-Q · filed 2012-05-04
$1.20M
derived: sum of 2 quarters · filed 2014-03-10
$15.55M
derived: sum of 3 quarters · filed 2014-03-10
$14.51M
derived: sum of 4 quarters · filed 2014-03-10
2011-12-31-$46.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10
$14.30M
derived: sum of 2 quarters · filed 2014-03-10
$13.26M
derived: sum of 3 quarters · filed 2014-03-10
$16.66M
10-K · filed 2014-03-10
$14.25M
10-K · filed 2012-03-09
2011-09-30$14.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01
$13.31M
derived: sum of 2 quarters · filed 2012-11-01
$16.70M
10-Q · filed 2012-11-01
$20.58M
derived: sum of 4 quarters · filed 2013-03-08
2011-06-30-$1.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
$2.36M
10-Q · filed 2012-08-03
$6.23M
derived: sum of 3 quarters · filed 2013-03-08
$7.04M
derived: sum of 4 quarters · filed 2013-03-08
2011-03-31$3.40M
10-Q · filed 2012-05-04
$7.27M
derived: sum of 2 quarters · filed 2013-03-08
$8.07M
derived: sum of 3 quarters · filed 2013-03-08
2010-12-31$3.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08
$4.68M
derived: sum of 2 quarters · filed 2013-03-08
-$8.45M
10-K · filed 2013-03-08
-$9.36M
10-K · filed 2012-03-09
2010-09-30$807.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
-$12.32M
10-Q · filed 2011-11-04
2010-06-30-$13.13M
10-Q · filed 2011-08-05
2009-12-31$14.84M
10-K · filed 2012-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45